Zum Inhalt springen
JAMA Clinical Reviews

JAMA Clinical Reviews

NeuDiagnosis and Treatment of Acute Ischemic Stroke12.11.2026 · 13 Min.
Folgen
508
Erscheint
wöchentlich
Letzte Folge
12. Nov. 2026

Über den Podcast

Author interviews that explore the latest clinical reviews.

Folgen 508

  1. Diagnosis and Treatment of Acute Ischemic Stroke

    13 Min.

    Ischemic stroke is a leading cause of disability and death and accounts for about 85% of strokes in the US. Author Gregory Albers, MD, of Stanford University Medical Center joins JAMA Deputy Editor Karen …

    Shownotes

    Ischemic stroke is a leading cause of disability and death and accounts for about 85% of strokes in the US. Author Gregory Albers, MD, of Stanford University Medical Center joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the diagnosis and treatment of ischemic stroke. Related Content:

  2. Idiosyncratic Drug-Induced Liver Injury: Diagnosis, Risk Factors, and Management

    17 Min.

    Idiosyncratic drug-induced liver injury is damage caused by prescription or over-the-counter medications or herbal dietary supplements that is not dose-dependent. JAMA Associate Editor Beverly Forsyth, MD …

    Shownotes

    Idiosyncratic drug-induced liver injury is damage caused by prescription or over-the-counter medications or herbal dietary supplements that is not dose-dependent. JAMA Associate Editor Beverly Forsyth, MD, speaks with author Naga Chalasani, MD, of Indiana University School of Medicine about risk factors, evaluation, and treatment of patients with idiosyncratic drug-induced liver injury. Related Content:

  3. Diagnosis and Management of Childhood Obesity

    18 Min.

    Childhood obesity affects approximately 15% of children aged 2 to 12 and is associated with adverse health outcomes in adulthood. Author Claudia K. Fox, MD, MPH, of the University of Minnesota Medical School …

    Shownotes

    Childhood obesity affects approximately 15% of children aged 2 to 12 and is associated with adverse health outcomes in adulthood. Author Claudia K. Fox, MD, MPH, of the University of Minnesota Medical School joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss epidemiology, diagnosis, and treatment of childhood obesity. Related Content:

  4. Heart Transplant for Advanced Heart Failure

    23 Min.

    Heart transplant for patients with advanced heart failure can lead to improved survival and quality of life. Author JoAnne Lindenfeld, MD, of Vanderbilt University joins JAMA Associate Editor David Simel, MD …

    Shownotes

    Heart transplant for patients with advanced heart failure can lead to improved survival and quality of life. Author JoAnne Lindenfeld, MD, of Vanderbilt University joins JAMA Associate Editor David Simel, MD, MHS, to discuss indications, transplant evaluation, management after transplant, long-term complications, and survival. Related Content:

  5. Narcolepsy: A Review

    21 Min.

    Narcolepsy is a chronic neurologic disorder that causes severe daytime sleepiness and impaired quality of life. Author Tom Scammell, MD, of Harvard Medical School joins JAMA Deputy Editor Karen Lasser, MD, MPH …

    Shownotes

    Narcolepsy is a chronic neurologic disorder that causes severe daytime sleepiness and impaired quality of life. Author Tom Scammell, MD, of Harvard Medical School joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the etiology, clinical presentation, diagnostic evaluation, and treatment of narcolepsy. Related Content:

  6. Influenza, RSV, and COVID-19 Vaccines: Effectiveness, Safety, and Trust in 2026

    14 Min.

    Respiratory virus vaccine effectiveness and safety for influenza, RSV, and COVID-19 are reviewed, including new evidence, risks, and recommendations. JAMA Deputy Editor Preeti Malani, MD, MSJ, speaks with …

    Shownotes

    Respiratory virus vaccine effectiveness and safety for influenza, RSV, and COVID-19 are reviewed, including new evidence, risks, and recommendations. JAMA Deputy Editor Preeti Malani, MD, MSJ, speaks with Rochelle Walensky, MD, MPH, professor of medicine at Harvard Medical School and former CDC Director, about vaccine data, public trust, and the 2026 respiratory virus season. Related Content:

  7. Vaccines for Cancer Treatment

    20 Min.

    Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells, facilitating destruction of cancer cells. Several vaccines are approved and others are in development …

    Shownotes

    Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells, facilitating destruction of cancer cells. Several vaccines are approved and others are in development for cancer treatment. Author Nora Disis, MD, JAMA Deputy Editor and Editor in Chief of JAMA Oncology, discusses cancer vaccines and more with JAMA Deputy Editor Mary McDermott, MD. Related Content:

  8. Idiopathic Normal Pressure Hydrocephalus: Diagnosis and Treatment

    19 Min.

    Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and is associated with gait impairment, cognitive decline, and urinary dysfunction. Author Mark …

    Shownotes

    Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and is associated with gait impairment, cognitive decline, and urinary dysfunction. Author Mark G. Luciano, MD, PhD, from Johns Hopkins University, discusses this and more with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content:

  9. Rheumatoid Arthritis

    23 Min.

    Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and treatment with DMARDs can reduce inflammation and lower the risk of joint destruction. JAMA Associate …

    Shownotes

    Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and treatment with DMARDs can reduce inflammation and lower the risk of joint destruction. JAMA Associate Editor David Simel, MD, MHS, is joined by review coauthor Josef Smolen, MD, to discuss this topic. Related Content:

  10. An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

    29 Min.

    POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. Author Satish Raj, MD, MSCI, of …

    Shownotes

    POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. Author Satish Raj, MD, MSCI, of University of Calgary Cumming School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss current evidence about the pathophysiology, diagnosis, and management of POTS. Related Content:

  11. Medication Treatments for Alcohol Use Disorder

    20 Min.

    Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen Holt, MD, MS, of Yale School of Medicine joins JAMA Deputy …

    Shownotes

    Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen Holt, MD, MS, of Yale School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss first-line pharmacotherapy for alcohol use disorder and important safety, efficacy, and hospital initiation considerations. Related Content:

  12. Liquid Biopsy Tests for Cancer

    24 Min.

    Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cancer after treatment, and identify genetic changes within cancer cells that could affect treatment response …

    Shownotes

    Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cancer after treatment, and identify genetic changes within cancer cells that could affect treatment response. Author Ben Ho Park, MD, PhD, of the Vanderbilt-Ingram Cancer Center discusses current evidence regarding use of liquid biopsies in management of cancer with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content:

  13. Patient-Clinician Communication About Physical Activity

    11 Min.

    Physical activity is an effective component of care for people with chronic medical conditions. In this podcast, JAMA Insights author Alessio Bricca, PhD, University of Southern Denmark, discusses adaptable …

    Shownotes

    Physical activity is an effective component of care for people with chronic medical conditions. In this podcast, JAMA Insights author Alessio Bricca, PhD, University of Southern Denmark, discusses adaptable methods to promote physical activity in patients with chronic medical conditions with host Anne Rentoumis Cappola, MD, ScM. Related Content:

  14. Classic Hodgkin Lymphoma

    21 Min.

    Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally in 2022, and 8720 cases reported in the US in 2025. Author Alison Moskowitz, MD, of Memorial Sloan …

    Shownotes

    Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally in 2022, and 8720 cases reported in the US in 2025. Author Alison Moskowitz, MD, of Memorial Sloan Kettering Cancer Center joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss current evidence about the diagnosis and management of Hodgkin lymphoma in adults. Related Content:

  15. The Sleep-Weight Connection

    14 Min.

    Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losing weight. In this podcast, JAMA Insights author Atul Malhotra, MD, from the University of California …

    Shownotes

    Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losing weight. In this podcast, JAMA Insights author Atul Malhotra, MD, from the University of California, San Diego, discusses evidence regarding sleep and obesity with JAMA Deputy Editor Mary McDermott, MD. Related Content:

  16. Management of Dyslipidemia

    23 Min.

    Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author Amber E …

    Shownotes

    Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author Amber E. Johnson, MD, MS, MBA, of the University of Chicago joins JAMA Senior Editor Philip Greenland, MD, to discuss the ACC/AHA guideline on management of dyslipidemia. Related Content:

  17. Hip Fractures: Management and Prevention

    19 Min.

    Hip fractures are a leading cause of disability and death in older adults. This episode summarizes risk factors, prevention, and medical and surgical management of hip fractures. JAMA Deputy Editor Mary M …

    Shownotes

    Hip fractures are a leading cause of disability and death in older adults. This episode summarizes risk factors, prevention, and medical and surgical management of hip fractures. JAMA Deputy Editor Mary M. McDermott, MD, interviews Douglas Kiel, MD, MPH, of Harvard Medical School and Marcus Institute for Aging Research. Related Content:

  18. Alcohol-Related Liver Disease

    20 Min.

    Alcohol-related liver disease is the leading cause of liver-related morbidity and mortality and the most common indication for liver transplant in Europe and the US. Author Aleksander Krag, MD, PhD, of the …

    Shownotes

    Alcohol-related liver disease is the leading cause of liver-related morbidity and mortality and the most common indication for liver transplant in Europe and the US. Author Aleksander Krag, MD, PhD, of the University of Southern Denmark joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss a recent review on this topic published in JAMA. Related Content:

  19. An Overview of Familial Hypercholesterolemia

    10 Min.

    Worldwide, heterozygous familial hypercholesterolemia (FH) affects approximately 1 in 250 to 350 individuals. Author James Stein, MD, of the University of Wisconsin School of Medicine and Public Health joins …

    Shownotes
    Worldwide, heterozygous familial hypercholesterolemia (FH) affects approximately 1 in 250 to 350 individuals. Author James Stein, MD, of the University of Wisconsin School of Medicine and Public Health joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the epidemiology, diagnosis, and treatment of both homozygous and heterozygous FH. Related Content:
  20. Transforming Communication Between Patients and Clinicians

    16 Min.

    Patient portal messaging continues to expand across health systems, and it has become an increasingly important method for patient-clinician communication. Authors Michal Mankowski, PhD, assistant professor …

    Shownotes

    Patient portal messaging continues to expand across health systems, and it has become an increasingly important method for patient-clinician communication. Authors Michal Mankowski, PhD, assistant professor, and Jane Long, MD, research resident, both from the Department of Surgery at NYU, discuss their new research letter with JAMA Deputy Editor Joseph Ross, MD, MHS. Related Content:

  21. Low Back Pain: Diagnosis and Treatment

    26 Min.

    Nonspecific low back pain is a leading cause of disability, with most cases lacking a clear anatomic cause. This episode reviews risk factors, diagnosis, and current evidence-based treatments for acute and …

    Shownotes

    Nonspecific low back pain is a leading cause of disability, with most cases lacking a clear anatomic cause. This episode reviews risk factors, diagnosis, and current evidence-based treatments for acute and chronic low back pain. JAMA Deputy Editor Mary M. McDermott, MD, interviews author James McAuley, PhD, of the University of New South Wales. Related Content:

  22. Survivors of Cyanotic Congenital Heart Disease

    23 Min.

    Cyanotic congenital heart diseases occur in approximately 0.2% of live births in the US, but survival to adulthood is common with current surgical interventions. JAMA Associate Editor David Simel, MD, MHS …

    Shownotes

    Cyanotic congenital heart diseases occur in approximately 0.2% of live births in the US, but survival to adulthood is common with current surgical interventions. JAMA Associate Editor David Simel, MD, MHS, speaks with author Michael Landzberg, MD, who coauthored a recent review in JAMA on this topic. Related Content:

  23. Point-of-Care Ultrasound for the Diagnosis of Pneumonia: A Review

    17 Min.

    Community-acquired pneumonia (CAP) accounts for 1.4 million emergency department visits and 740 000 hospitalizations annually in the US. Author Andre Kumar, MD, MEd, of Stanford University School of Medicine …

    Shownotes

    Community-acquired pneumonia (CAP) accounts for 1.4 million emergency department visits and 740 000 hospitalizations annually in the US. Author Andre Kumar, MD, MEd, of Stanford University School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the use of point-of-care ultrasound for diagnosis of CAP. Related Content:

  24. Cesarean Delivery on Request

    15 Min.

    Cesarean delivery on maternal request requires individualized counseling. Reduced risks of pelvic floor disorders should be weighed against surgical risks and future risks including abnormal placentation …

    Shownotes

    Cesarean delivery on maternal request requires individualized counseling. Reduced risks of pelvic floor disorders should be weighed against surgical risks and future risks including abnormal placentation. Author Marianna Alperin, MD, MS, from UC San Diego School of Medicine, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD. Related Content:

  25. Diet and Exercise Recommendations for Patients Taking GLP-1 Receptor Agonists

    14 Min.

    The GLP-1 receptor agonists reduce appetite and greatly facilitate weight loss. Robert Kushner, MD, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to …

    Shownotes

    The GLP-1 receptor agonists reduce appetite and greatly facilitate weight loss. Robert Kushner, MD, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss appropriate diet and exercise recommendations for patients receiving GLP-1 receptor agonists for weight loss. Related Content:

  26. An Overview of Amyotrophic Lateral Sclerosis

    18 Min.

    Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS …

    Shownotes

    Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Ravits, MD, of UC San Diego School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of ALS. Related Content:

  27. Hepatitis B: Global Insights on Transmission and Treatment

    22 Min.

    Hepatitis B virus (HBV) infection affects around 254 million people worldwide and causes more than 1 million deaths annually. Author Anna Lok, MD, from the University of Michigan discusses HBV transmission …

    Shownotes

    Hepatitis B virus (HBV) infection affects around 254 million people worldwide and causes more than 1 million deaths annually. Author Anna Lok, MD, from the University of Michigan discusses HBV transmission, screening, and treatment with JAMA Associate Editor Beverly Forsyth, MD. Related Content:

  28. Review of Cardiac Resynchronization Therapy

    20 Min.

    Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author …

    Shownotes

    Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac resynchronization therapy with JAMA Associate Editor David Simel, MD, MHS. Related Content:

  29. Prepregnancy Care and Counseling to Improve Maternal and Neonatal Outcomes

    18 Min.

    In the US, approximately 66% of reproductive-aged women have at least 1 modifiable risk factor for adverse pregnancy outcomes. Authors and ob-gyns Kylie Cooper, MD, and Daniel Breitkopf, MD, both from the Mayo …

    Shownotes

    In the US, approximately 66% of reproductive-aged women have at least 1 modifiable risk factor for adverse pregnancy outcomes. Authors and ob-gyns Kylie Cooper, MD, and Daniel Breitkopf, MD, both from the Mayo Clinic, discuss ways to reduce maternal morbidity and mortality and improve neonatal outcomes with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content:

  30. Diagnosis and Management of Endometrial Cancer

    14 Min.

    Endometrial cancer accounts for 95% of uterine cancers, which are the fourth most common cancer in women in the US. Author Karen McLean, MD, PhD, of Roswell Park Comprehensive Cancer Center joins JAMA Senior …

    Shownotes

    Endometrial cancer accounts for 95% of uterine cancers, which are the fourth most common cancer in women in the US. Author Karen McLean, MD, PhD, of Roswell Park Comprehensive Cancer Center joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about diagnosis and treatment of endometrial cancer. Related Content:

Hier stehen die neuesten 40 von 508 Folgen. Ältere Folgen findest du im Feed des Podcasts.

Ist das dein Podcast?

Bestätige es mit einem Eintrag in deinem Feed: Du bekommst hier einen Code, trägst ihn als podcast:txt in den Kanal deines Feeds ein, und wir prüfen ihn. Danach steht dein Podcast als „verifiziert“ bei SoundNode.

Einstellungen

Darstellung

Sprache

Bestimmt, welche Sender dir auf der Startseite zuerst gezeigt werden.

Verlauf

Zuletzt gehörte Sender und Folgen und deine letzten Suchen liegen nur in diesem Browser.

Hinweise

Ein kurzer Hinweis, wenn ein Podcast, dem du folgst, eine neue Folge hat. Einzelne Podcasts stellst du über die Glocke auf ihrer Seite ab.

Konto

Favoriten speichern – in der App und auf der Website.

Tastenkürzel

/
Suche öffnen
Leertaste
Abspielen oder anhalten
← →
Im Player: 15 s zurück, 30 s vor (Folgen) · im Regal: nächste Kachel
↑ ↓
Im Regal: Ziel innerhalb der Kachel
Pos1 / Ende
Im Regal: erste bzw. letzte Kachel
Esc
Fenster oder Menü schließen
?
Diese Übersicht
Läuft gerade

Zur Senderseite

Als Nächstes

    Folgen mit „Als Nächstes“ vormerken – sie laufen nach der aktuellen Folge.